- Home
- HGV vs ACLX Comparison
HGV vs ACLX Comparison
Compare HGV & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGV
- ACLX
- Stock Information
- Founded
- HGV 1992
- ACLX 2015
- Country
- HGV United States
- ACLX United States
- Employees
- HGV N/A
- ACLX N/A
- Industry
- HGV Hotels/Resorts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- HGV Consumer Discretionary
- ACLX Health Care
- Exchange
- HGV Nasdaq
- ACLX Nasdaq
- Market Cap
- HGV 3.8B
- ACLX 3.6B
- IPO Year
- HGV N/A
- ACLX 2022
- Fundamental
- Price
- HGV $41.02
- ACLX $63.75
- Analyst Decision
- HGV Buy
- ACLX Strong Buy
- Analyst Count
- HGV 9
- ACLX 14
- Target Price
- HGV $45.22
- ACLX $107.67
- AVG Volume (30 Days)
- HGV 612.6K
- ACLX 532.8K
- Earning Date
- HGV 02-27-2025
- ACLX 02-26-2025
- Dividend Yield
- HGV N/A
- ACLX N/A
- EPS Growth
- HGV N/A
- ACLX N/A
- EPS
- HGV 0.89
- ACLX N/A
- Revenue
- HGV $4,238,000,000.00
- ACLX $155,818,000.00
- Revenue This Year
- HGV $40.51
- ACLX $12.58
- Revenue Next Year
- HGV $5.47
- ACLX N/A
- P/E Ratio
- HGV $46.02
- ACLX N/A
- Revenue Growth
- HGV 18.38
- ACLX 230.33
- 52 Week Low
- HGV $33.21
- ACLX $47.88
- 52 Week High
- HGV $49.02
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- HGV 47.26
- ACLX 41.49
- Support Level
- HGV $40.61
- ACLX $62.38
- Resistance Level
- HGV $43.59
- ACLX $67.00
- Average True Range (ATR)
- HGV 1.21
- ACLX 2.82
- MACD
- HGV -0.07
- ACLX 0.32
- Stochastic Oscillator
- HGV 37.62
- ACLX 28.44
About HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.